Hire an Advanced Robo-Advisor to Trade PFE on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Smart Auto-Trading?
Smart Auto-Trading is an advanced Robo-Advisor designed to provides investors with a trading partner to automate systematic investing. Its robo is designed to screen, monitor and auto-trade elite stocks like PFIZER, INC. (PFE) using Artificial Intelligence, social media and market data to augments your potential as an investor.
Smart Auto-Trading produces short-term trades which makes it ideal for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMAs. It also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.
Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest, one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $25,000 in your account and connect Smart Auto-Trading to trade.
There are clear benefits associated with using a Robo-Advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few easy steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Robo investing really means that a computer program is tasked to monitor and trade stocks based on your carefully crafted strategy.
Robo investing simplifies stock investing by processing and organizing stocks for the purpose of trading.
Once your strategy is set up, all you need to do is start your simulation. The Robo-Advisor then executes your strategy by finding and trading stocks that meet specific requirements.
Because you can test and improve your strategy over time, the AI empowers you to find the appropriate strategy without risking your capital.
Time is your ally when it comes down to AI investing. Take your time to refine your simulation and learn about the capabilities of the technology. Patterns will reveal themselves and empower you to develop your real potential.
Smart Auto-Trading is one of the first Robo-Advisor to take advantage of Government grade listening technology, Artificial Intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.
PFIZER, INC. (PFE) News
Company stock that will influence your investment decision: Pfizer Inc. (PFE)
The following data is for Pfizer Inc. | NYSE: PFE | Friday, January 5, 2018
Based on the aggregate value of the company over its current share price and the total amount of outstanding stocks, the market cap of Pfizer Inc. (PFE) is presently reeling at 220.2B. Acting as the blue chip in today’s trade, Pfizer Inc.’s existing market cap value showcases its prevailing assets, capital and revenues. It also indicates that the share tends to be less volatile and proves to be more attractive than smaller companies because of their stability and the likelihood of higher dividend offers.
The company’s P/E ratio is currently valued at 22.6, with a forward P/E of 13.36. The existing P/E value will allow investors to easily determine whether the company’s stock price is cheap or expensive. Corporations that acquires a higher P/E ratio are usually growth stocks. However, their relatively high multiples do not necessarily indicate that their shares are overpriced and not good buys for the long term.
Pfizer Inc. has a current ratio of 1.4, indicating whether the company’s short-term assets (cash, cash equivalents, marketable securities, receivables and inventory) are readily obtainable to pay off its short-term liabilities. Theoretically, the higher the current ratio, the better. The corporation holds a quick ratio of 1.1, signifying the short-term liquidity and the ability to use its quick assets to pay the current liabilities. However, investors should also know that this is not the whole story on company liquidity.
It’s ROA is valued at 5.80% marking the total profit the company generates as a percentage of the value of its total assets. Generally, the higher the ROA, the better it is. A falling ROA is almost always a problem, but investors and analysts should also know that the ROA does not account for outstanding liabilities and may signpost a greater profit level than actually derived. The firm has a ROI of 7.80%, calculating the gain or loss generated on investment relative to the sum of money invested. Return on investments is normally expressed as a percentage and is used for personal financial decisions. The existing ROI value of Pfizer Inc. outlines the firm’s profitability alongside the efficiency of different investments.
Pfizer Inc. has an EPS value of 1.63, demonstrating the portion of the company’s earnings, net of taxes and preferred stock dividends that is allotted to each share of common stock. The current amount sensibly gauges the company’s liability per unit of shareholder ownership and indicates whether it is a key driver of share prices. The current share price of Pfizer Inc. is valued at $36.79 with a change in price of 0.22%. Company has a target price of $38.29.
The existing EPS value gives an insight into the company’s EPS growth this year at 5.20%. With this in mind, the EPS growth for the following year measures at 6.09%. It has an EPS growth of 3.30% for the past five years, indicating an EPS value of 5.90% for the next five years. The sales growth for the past five years is -2.80%.Get Started today! - Risk Free